Form Type: 4

SEC EDGAR Link
Accession Number:0001127602-23-004926
Date:2023-02-09
Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
Original Submission Date:

Reporting Person:

CRUM BRIAN T
2445 TECHNOLOGY FOREST BLVD.
11TH FLOOR THE WOODLANDS, TX 77381

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
RESTRICTED STOCK UNITS 0.0 2023-02-09 deemed execution date A 100,370 (a) common stock 100,370 $0.00 100,370 direct
STOCK OPTION (RIGHT TO BUY) 2.43 2023-02-09 deemed execution date A 301,100 (a) 2033-02-09 common stock 301,100 $2.43 301,100 direct
Footnotes
IDfootnote
f1 each restricted stock unit represents a contingent right to receive one share of common stock.
f2 restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on february 28 of each of the three years following the year of grant.
f3 option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.
WhaleWisdom Logo

Elevate your investments